SCHEMBL8380925

SCHEMBL8380925

CC(CN1CCN(C(=O)OC(C)(C)C)CC1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.54
CHRM2 P08172 1/20 0.53
CHRM4 P08173 1/20 0.53
CHRM1 P11229 1/20 0.53
CHRM3 P20309 1/20 0.53
ALDH1A1 P00352 6/20 0.52
KDM4E B2RXH2 4/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
GFER P55789 1/20 0.52
NPC1 O15118 1/20 0.50
MAPT P10636 1/20 0.50
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
RAB9A P51151 1/20 0.50
GPR119 Q8TDV5 2/20 0.48
ATM Q13315 1/20 0.47
PKM P14618 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8380927 1.00 ABCB1 (0.54) ABCB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL8431248 0.93 ABCB1 (0.49) ABCB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL5400970 0.86 CHRM1 (0.55) ABCB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL8473520 0.86 CYP3A4 (0.53) ABCB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL8473516 0.86 CYP3A4 (0.53) ABCB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL8332282 0.85 ABCB1 (0.53) ABCB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL8336752 0.83 ABCB1 (0.53) ABCB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL8377313 0.82 GPR119 (0.50) ABCB1CHRM2CHRM4CHRM1CHRM3
SCHEMBL13150327 0.81 ALDH1A1 (0.57) ALDH1A1KDM4EL3MBTL1GFERNPC1
SCHEMBL14593289 0.80 ABCB1 (0.51) ABCB1CHRM2CHRM4CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7304077-B2 Chemical compounds ASTRAZENECA AB (SE) 2007-12-04 US disclosed
US-20070179297-A1 Chemical compounds ASTRAZENECA AB, A SWEDEN CORPORATION 2007-08-02 US disclosed
US-7238811-B2 Chemical compounds ASTRAZENECA AB (SE) 2007-07-03 US disclosed
US-7179922-B2 4-Phenyloxypiperidionopiperidine compounds as antiinflammatory agents; autoimmune diseases; rheumatic diseases; cardiovascular disorders ASTRAZENECA AB (SE) 2007-02-20 US disclosed
US-5998416-A Piperazine, piperidine and tetrahydropyridine derivatives as 5-HT receptor agonists MERCK SHARP & DOHME LTD. (GB) 1999-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179297-A1 Chemical compounds CCR3, CCR1, CCR4 ABCB1 622/4885CHRM2 354/4885CHRM4 389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.